Varex imaging corporation (VREX)
CashFlow / Quarterly
Apr'20Jan'20Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15
Cash flows from operating activities:
Net (loss) earnings

-1,800

-1,200

8,200

-1,300

5,900

3,000

400

4,000

12,500

11,400

15,000

10,800

15,000

11,200

22,200

17,800

14,800

14,200

Adjustments to reconcile net earnings to net cash provided by operating activities:
Share-based compensation expense

3,300

3,200

3,000

3,100

3,000

2,600

2,500

2,800

2,600

2,100

2,300

2,500

1,300

2,300

2,500

2,400

2,500

2,100

Depreciation

6,200

5,200

4,800

4,600

4,300

9,800

10,000

5,500

5,600

4,900

6,300

2,100

5,400

3,100

2,600

2,800

1,900

2,500

Amortization of intangible assets

4,400

4,500

4,300

4,100

3,600

3,700

3,700

4,100

4,200

4,200

4,300

3,600

1,300

1,300

1,300

1,300

1,400

1,500

Deferred taxes

-200

500

-

-3,100

-100

-2,500

-

-2,900

-1,200

-9,900

-

900

1,700

5,200

-

-8,100

7,900

1,200

Income from equity method investments

-1,400

700

-1,600

-1,000

-500

800

700

0

3,900

-700

-1,700

2,600

300

100

-500

-800

500

-800

Amortization of deferred loan costs

600

600

600

600

600

600

600

500

600

600

1,200

600

0

0

-

-

-

-

Other, net

-200

0

200

400

-1,300

-100

-1,300

600

0

0

-1,200

0

-400

-200

-100

-600

600

-600

Changes in assets and liabilities, net of effects of acquisition:
Accounts receivable

3,800

-18,500

10,300

4,300

-8,800

-20,600

23,500

1,900

-800

-33,600

30,300

-6,900

9,600

-9,900

13,400

-9,900

-3,900

5,000

Inventories

13,100

21,100

-15,100

-200

4,400

22,000

-10,400

1,800

1,400

9,600

-19,900

8,900

8,500

6,700

900

11,100

7,800

3,700

Prepaid expenses and other assets

9,600

-3,700

400

-2,200

1,200

-3,700

800

-1,500

-1,300

0

2,700

-400

5,400

2,400

1,300

-500

700

-600

Accounts payable

5,600

15,400

-4,700

-1,600

-2,200

-500

7,900

4,500

-8,700

1,500

-5,800

3,400

9,200

-1,900

-400

2,200

-4,500

800

Accrued liabilities and other current and long-term operating liabilities

5,700

-4,800

11,400

3,900

-7,500

3,100

-3,200

-1,000

-7,100

1,100

18,600

7,100

4,800

-2,400

3,000

6,700

2,000

-8,900

Deferred revenues

2,000

-800

-3,300

0

-500

-1,400

2,300

500

100

-500

400

0

-1,500

-500

0

2,000

500

-600

Net cash provided by operating activities

900

23,000

22,900

16,100

12,900

20,000

18,500

21,300

5,400

40,100

15,400

26,800

13,800

19,200

19,800

27,500

20,800

6,100

Cash flows from investing activities:
Purchases of property, plant and equipment

6,100

8,100

6,500

5,700

4,200

3,400

5,100

8,400

4,300

2,600

12,600

900

1,700

5,000

4,700

5,100

8,600

10,500

Sale of available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

8,600

Acquisitions of businesses, net of cash acquired

0

1,200

0

69,500

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Investments in privately-held companies

600

1,300

-

3,600

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Other

-

-

-

-

-

-

-

-

-

-

-

-

-

-700

-

-

-

0

Net cash used in investing activities

-6,700

-10,600

-6,800

-78,800

-4,200

-3,400

-9,900

-8,400

-4,300

-2,600

-8,400

-276,900

-2,400

-4,300

-4,700

-6,400

-8,600

-1,900

Cash flows from financing activities:
Net transfers from parent

-

-

-

-

-

-

-

-

-

-

-

-11,200

12,700

1,800

-

-

-

-

Net transfers from parent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-36,700

0

-9,500

9,500

Borrowings under credit agreements

20,500

3,000

6,400

72,000

3,000

4,000

0

0

8,000

2,000

5,000

538,000

206,000

0

-

-

-

-

Repayments of borrowing under credit agreements

18,700

17,800

21,300

13,700

33,000

19,000

10,000

18,000

46,000

32,000

21,000

230,200

3,800

0

-

-

-

-

Proceeds from exercise of stock options

400

1,100

600

100

100

0

300

1,300

400

1,800

0

2,200

600

0

-

-

-

-

Proceeds from shares issued under employee stock purchase plan

0

1,800

0

1,900

0

1,900

0

1,900

0

1,400

-

-

-

-

-

-

-

-

Excess tax benefits from share-based compensation

-

-

-

-

-

-

-

-

-

-

2,400

0

0

0

-

-

-

-

Other financing activities

0

-100

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used in financing activities

-100

-12,000

-14,800

60,300

-32,500

-13,100

-8,900

-14,800

-39,900

-26,800

-12,600

259,800

14,300

1,800

-12,700

-25,100

-8,500

9,500

Effects of exchange rate changes on cash and cash equivalents and restricted cash

100

-300

0

-100

-200

-400

0

-700

100

100

200

0

0

700

0

0

-300

400

Net increase in cash and cash equivalents and restricted cash

-5,800

100

1,300

-2,500

-24,000

3,100

-300

-2,600

-38,700

10,800

-5,400

9,700

25,700

17,400

2,400

-4,000

3,400

14,100

Supplemental cash flow information:
Cash paid for interest

4,200

5,000

6,200

4,600

6,100

3,000

4,700

4,700

4,900

5,000

5,400

3,500

900

0

-

-

-

-

Cash paid for income tax

5,900

500

4,400

3,500

-300

600

1,200

700

11,700

200

3,400

2,600

0

0

-

-

-

-

Supplemental non-cash activities:
Purchases of property, plant and equipment financed through accounts payable

100

800

1,600

-400

-1,200

1,800

-500

-3,000

3,500

2,000

2,600

-1,200

-1,000

3,600

-500

0

0

3,600

Transfers of property, plant and equipment from Varian Medical Systems, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0